跳转至内容
Merck

D3897

Sigma-Aldrich

2'-脱氧胞苷

≥99% (HPLC)

别名:

2'-脱氧胞嘧啶核苷

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C9H13N3O4
CAS号:
分子量:
227.22
Beilstein:
87567
EC號碼:
MDL號碼:
分類程式碼代碼:
41106305
PubChem物質ID:
NACRES:
NA.51

生物源

synthetic (organic)

化驗

≥99% (HPLC)

形狀

powder

溶解度

water: 50 mg/mL, clear, colorless to very faintly yellow

儲存溫度

−20°C

SMILES 字串

NC1=NC(=O)N(C=C1)[C@H]2C[C@H](O)[C@@H](CO)O2

InChI

1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1

InChI 密鑰

CKTSBUTUHBMZGZ-SHYZEUOFSA-N

一般說明

2′-脱氧胞苷(deoxyC)是一种以胞嘧啶作为核碱基的脱氧核苷。存在于血液、粪便和尿液中。

應用

2′-脱氧胞苷已用于:
  • 作为布氏锥虫Trypanosoma brucei 胞苷脱氨酶(TbCDA)底物检测其活性
  • 作为鼠肿瘤组织间液代谢物液相色谱-质谱法(LC–MS)分离和定量分析的标准品
  • 研究自噬在癌基因和DNA复制压力下的作用

生化/生理作用

2′-脱氧胞苷(deoxyC)可磷酸化形成dCTP,再由各种DNA聚合酶或逆转录酶合成DNA。2-脱氧胞苷是脱氧胞苷脱氨酶(EC 3.5.4.14)的底物,该酶可将其转化为2′-脱氧尿苷。2-脱氧胞苷可在脱氧胞苷激酶(DCK)的磷酸化作用下成为核苷酸——脱氧胞苷单磷酸(dCMP)。2-脱氧胞苷可作为头颈癌标志物。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Urinary Nucleosides and Deoxynucleosides
Patejko M, et al.
Advances in Clinical Chemistry, 83, 1-51 (2018)
Ana Moro-Bulnes et al.
mSphere, 4(4) (2019-08-09)
Cytidine deaminase (CDA) is a pyrimidine salvage enzyme that catalyzes cytidine and deoxycytidine hydrolytic deamination to yield uridine and deoxyuridine. Here we report the biochemical characterization of Trypanosoma brucei CDA as an enzyme within the tetrameric class of the CDA
Martyna Modrzejewska et al.
Free radical biology & medicine, 101, 378-383 (2016-11-12)
The most plausible mechanism behind active demethylation of 5-methylcytosine involves TET proteins which participate in oxidation of 5-methylcytosine to 5-hydroxymethylcytosine; the latter is further oxidized to 5-formylcytosine and 5-carboxycytosine. 5-Hydroxymethyluracil can be also generated from thymine in a TET-catalyzed process.
Megan Beetch et al.
Scientific reports, 10(1), 2415-2415 (2020-02-14)
Triple-negative breast cancer (TNBC) is a subtype of breast cancer unresponsive to traditional receptor-targeted treatments, leading to a disproportionate number of deaths. Invasive breast cancer is believed to evolve from non-invasive ductal carcinoma in situ (DCIS). Detection of triple-negative DCIS
Santiago Uribe-Lewis et al.
Genome biology, 16, 69-69 (2015-04-09)
The discovery of cytosine hydroxymethylation (5hmC) as a mechanism that potentially controls DNA methylation changes typical of neoplasia prompted us to investigate its behaviour in colon cancer. 5hmC is globally reduced in proliferating cells such as colon tumours and the

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门